DUBLIN--(BUSINESS WIRE)--Aug 31, 2018--The "Progressive Multifocal Leukoencephalopathy - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'Progressive Multifocal Leukoencephalopathy - Pipeline Insight, 2018' report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Progressive Multifocal Leukoencephalopathy development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Key Topics Covered:

1. Report Introduction

2. Progressive Multifocal Leukoencephalopathy Overview

3. Pipeline Therapeutics

An Overview of Pipeline Products for Progressive Multifocal Leukoencephalopathy

4. Comparative Analysis

5. Products in Clinical Stage

Product Description Research and Development Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

Product Description Research and Development Product Development Activities

7. Therapeutic Assessment

Assessment by Route of Administration Assessment by Stage and Route of Administration Assessment by Molecule Type Assessment by Stage and Molecule Type

8. Inactive Products

Product Description Research and Development Product Development Activities

Companies Mentioned

Excision BioTherapeutics Inc Neurimmune Holding AG Neuway Pharma GmbH Pomona Ricerca SRL Inhibikase Therapeutics

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/hgzjnz/progressive?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180831005418/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs ,Infectious Diseases Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/31/2018 01:46 PM/DISC: 08/31/2018 01:46 PM

http://www.businesswire.com/news/home/20180831005418/en